RNXT · RenovoRx, Inc.

$1.20 -0.20 (-14.29%)

Market Cap

$63.18M

45.13M

Private capital raises reported to the SEC on Form D under Regulation D, showing the offering size, amount sold, minimum investment and number of investors. Public operating companies rarely raise capital this way, so this page is often empty.

Filed	Type	Industry	Offering	Sold	Min. Invest.	Investors	Exemptions
2026-04-09	New	Biotechnology	$10,000,000	$9,999,929	$10,000	16	06b
2024-04-22	New	Biotechnology	$15,000,000	$11,136,557	—	172	06b
2024-02-09	New	Other Health Care	$15,000,000	$6,111,695	$10,000	92	06c

Showing 1–3 of 3 filings

Key facts CIK 1574094 CUSIP 75989R107 13F (30d) 27 filings 27 filers Visit website Investor relations